✦ LIBER ✦

Correction of glycaemia and GLUT1 level by mildronate in rat streptozotocin diabetes mellitus model

✍ Scribed by Jelizaveta Sokolovska; Sergejs Isajevs; Olga Sugoka; Jelena Sharipova; Lasma Lauberte; Darja Svirina; Evita Rostoka; Tatjana Sjakste; Ivars Kalvinsh; Nikolajs Sjakste

Book ID: 102788206
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 609 KB
Volume: 29
Category: Article
ISSN: 0263-6484
DOI: 10.1002/cbf.1719

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Telithromycin Pharmacokinetics in Rat Mo

Telithromycin Pharmacokinetics in Rat Model of Diabetes Mellitus Induced by Alloxan or Streptozotocin

✍ Joo H. Lee; Myung G. Lee 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 198 KB

The influence of mildronate on periphera

The influence of mildronate on peripheral neuropathy and some characteristics of glucose and lipid metabolism in rats with the streptozotocin model of diabetes mellitus

✍ Sokolovska, J.; Rumaks, J.; Karajeva, N.; Grinvalde, D.; Sharipova, J.; Kluša, V 📂 Article 📅 2012 🏛 Pleiades Publishing 🌐 English ⚖ 157 KB

Normalization of endothelial dysfunction

Normalization of endothelial dysfunction and vascular oxidative stress by chronic atorvastatin treatment in a rat model of streptozotocin-induced diabetes mellitus (type I)

✍ Matthias Oelze; Philip Wenzel; Lena Steinhoff; Moritz Brandt; Andrei L. Kleschyo 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Pharmacokinetics of diclofenac in rat mo

Pharmacokinetics of diclofenac in rat model of diabetes mellitus induced by alloxan or steptozotocin

✍ Yu C. Kim; Eun Y. Oh; So H. Kim; Myung G. Lee 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 3 views

Liquiritigenin pharmacokinetics in a rat

Liquiritigenin pharmacokinetics in a rat model of diabetes mellitus induced by streptozotocin: greater formation of glucuronides in the liver, especially M2, due to increased hepatic uridine 5′-diphosphoglucuronic acid level

✍ Hee E. Kang; Se I. Sohn; Seung R. Baek; Jee W. Lee; Myung G. Lee 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 455 KB

Empagliflozin, a novel potent and select

Empagliflozin, a novel potent and selective SGLT-2 inhibitor, improves glycaemic control alone and in combination with insulin in streptozotocin-induced diabetic rats, a model of type 1 diabetes mellitus

✍ G. Luippold; T. Klein; M. Mark; R. Grempler 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 701 KB